Literature DB >> 18170984

Preparation and ocular pharmacokinetics of ganciclovir liposomes.

Yan Shen1, Jiasheng Tu.   

Abstract

Ophthalmic liposomes of ganciclovir (GCV) were prepared by the reverse phase evaporation method, and their ocular pharmacokinetics in albino rabbits were compared with those obtained after dosing with GCV solution. The in vitro transcorneal permeability of GCV liposomes was found to be 3.9-fold higher than that of the solution. After in vivo instillation in albino rabbits, no difference was found in the precorneal elimination rate of GCV from liposome vs solution dosing. The aqueous humor concentration-time profiles of both liposomes and solution were well described by 2-compartmental pharmacokinetics with first-order absorption. The area under the curve of the aqueous humor concentration-time profiles of GCV liposomes was found to be 1.7-fold higher than that of GCV solution. Ocular tissue distribution of GCV from liposomes was 2 to 10 times higher in the sclera, cornea, iris, lens, and vitreous humor when compared with those observed after solution dosing. These results suggested that liposomes may hold some promise in ocular GCV delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18170984      PMCID: PMC2751489          DOI: 10.1208/aapsj0903044

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  16 in total

1.  The characterization and biodistribution of cefoxitin-loaded liposomes.

Authors:  Pao-Chu Wu; Yi-Hung Tsai; Chung-Cheng Liao; Jui-Sheng Chang; Yaw-Bin Huang
Journal:  Int J Pharm       Date:  2004-03-01       Impact factor: 5.875

2.  Deformable liposomes and ethosomes: mechanism of enhanced skin delivery.

Authors:  Mustafa M A Elsayed; Ossama Y Abdallah; Viviane F Naggar; Nawal M Khalafallah
Journal:  Int J Pharm       Date:  2006-05-19       Impact factor: 5.875

3.  An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation.

Authors:  Yahya E Choonara; Viness Pillay; Trevor Carmichael; Michael P Danckwerts
Journal:  Int J Pharm       Date:  2006-02-07       Impact factor: 5.875

4.  Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.

Authors:  S L Law; K J Huang; C H Chiang
Journal:  J Control Release       Date:  2000-01-03       Impact factor: 9.776

5.  Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.

Authors:  J J McSharry; A McDonough; B Olson; C Talarico; M Davis; K K Biron
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 6.  Is combination antiviral therapy for CMV superior to monotherapy?

Authors:  W Lawrence Drew
Journal:  J Clin Virol       Date:  2006-01-18       Impact factor: 3.168

7.  Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results.

Authors:  H L Cantrill; K Henry; N H Melroe; W H Knobloch; R C Ramsay; H H Balfour
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

8.  Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.

Authors:  P M Hughes; A K Mitra
Journal:  J Ocul Pharmacol       Date:  1993

9.  Retention of topical liposomal formulations on the cornea.

Authors:  T A McCalden; M Levy
Journal:  Experientia       Date:  1990-07-15

Review 10.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

View more
  13 in total

1.  Synthesis and Characterization of Ganciclovir Long Chain Lipid Prodrugs.

Authors:  Kishore Cholkar; Hoang M Trinh; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Adv Ophthalmol Vis Syst       Date:  2014-08-27

Review 2.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

3.  Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: cytotoxicity evaluation in vitro and ex vivo.

Authors:  Manisha Choudhari; Kritika Nayak; Noriaki Nagai; Yosuke Nakazawa; Dignesh Khunt; Manju Misra
Journal:  Int Ophthalmol       Date:  2022-09-26       Impact factor: 2.029

Review 4.  Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.

Authors:  Yaru Wang; Changhong Wang
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

Review 5.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

6.  Recent applications of liposomes in ophthalmic drug delivery.

Authors:  Gyan P Mishra; Mahuya Bagui; Viral Tamboli; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2011-03-01

Review 7.  Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.

Authors:  Rinda Devi Bachu; Pallabitha Chowdhury; Zahraa H F Al-Saedi; Pradeep K Karla; Sai H S Boddu
Journal:  Pharmaceutics       Date:  2018-02-27       Impact factor: 6.321

8.  Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Authors:  Monika Yadav; Nicola Schiavone; Ana Guzman-Aranguez; Fabrizio Giansanti; Laura Papucci; Maria J Perez de Lara; Mandeep Singh; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617

9.  Partitioning and Spatial Distribution of Drugs in Ocular Surface Tissues.

Authors:  Anusha Balla; Seppo Auriola; Angus C Grey; Nicholas J Demarais; Annika Valtari; Emma M Heikkinen; Elisa Toropainen; Arto Urtti; Kati-Sisko Vellonen; Marika Ruponen
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

10.  Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats.

Authors:  Usha Ganganahalli Kapanigowda; Sree Harsha Nagaraja; Balakeshwa Ramaiah; Prakash Rao Boggarapu
Journal:  Daru       Date:  2015-10-24       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.